Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study

References

• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case controlled study. Lancet. 2004;364(9438):937–952. doi: 10.1016/S0140-6736(04)17018-9.
   PubMed Web of Science ®Google Scholar
• Gaudet D, Alexander VJ, Baker BF, et al. Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia. N Engl J Med. 2015;373(5):438–447. doi: 10.1056/NEJMoa1400283.
   PubMed Web of Science ®Google Scholar
• LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med. 1997;157(9):961–968. doi: 10.1001/archinte.1997.00440300051004.
   PubMedGoogle Scholar
• Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N Engl J Med. 2014;371(1):32–41. doi: 10.1056/NEJMoa1308027.
   PubMed Web of Science ®Google Scholar
• Dugani SB, Moorthy MV, Li C, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol. 2021;6(4):437–447. doi: 10.1001/jamacardio.2020.7073.
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Handelsman DJ, et al. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022;3(2):e109–e118. doi: 10.1016/S2666-7568(22)00001-0.
   PubMedGoogle Scholar
• Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab. 2010;95(2):740–747. doi: 10.1210/jc.2009-1693.
   PubMed Web of Science ®Google Scholar
• Sievers C, Klotsche J, Pieper L, et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol. 2010;163(4):699–708. doi: 10.1530/EJE-10-0307.
   PubMed Web of Science ®Google Scholar
• Naessen T, Sjogren U, Bergquist J, et al. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab. 2010;95(4):1889–1897. doi: 10.1210/jc.2009-1722.
   PubMed Web of Science ®Google Scholar
• Debing E, Peeters E, Duquet W, et al. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. Eur J Endocrinol. 2007;156(6):687–693. doi: 10.1530/EJE-06-0702.
   PubMed Web of Science ®Google Scholar
• Bernini GP, Sgro’ M, Moretti A, et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab. 1999;84(6):2008–2012. doi: 10.1210/jcem.84.6.5824.
   PubMed Web of Science ®Google Scholar
• Golden SH, Maguire A, Ding J, et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol. 2002;155(5):437–445. doi: 10.1093/aje/155.5.437.
   PubMed Web of Science ®Google Scholar
• Marra AM, D’Assante R, Salzano A, et al. Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry. ESC Heart Fail. 2022;10(1):159–166.
   Google Scholar
• Davison S, Thipphawong J, Blanchard J, et al. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. J Clin Pharmacol. 2005;45(2):177–184. doi: 10.1177/0091270004269840.
   PubMed Web of Science ®Google Scholar
• Worboys S, Kotsopoulos D, Teede H, et al. Evidence that parenteral testosterone therapy may improve endothelium-dependent and-independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab. 2001;86(1):158–161. doi: 10.1210/jcem.86.1.7103.
   PubMed Web of Science ®Google Scholar
• Montalcini T, Gorgone G, Gazzaruso C, et al. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis. 2007;18(1):9–13. doi: 10.1097/01.mca.0000236290.79306.d1.
   PubMed Web of Science ®Google Scholar
• Budoff M. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease. Am J Cardiol. 2016;118(1):138–145. doi: 10.1016/j.amjcard.2016.04.004.
   PubMed Web of Science ®Google Scholar
• Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–2373. doi: 10.1016/j.jacc.2009.10.009.
   PubMed Web of Science ®Google Scholar
• Derby CA, Crawford SL, Pasternak RC, et al. Lipid changes during the menopause transition in relation to age and weight: the Study of Women’s Health across the Nation. Am J Epidemiol. 2009;169(11):1352–1361. doi: 10.1093/aje/kwp043.
   PubMed Web of Science ®Google Scholar
• Worsley R, Robinson PJ, Bell RJ, et al. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause. 2013;20(6):640–645. doi: 10.1097/GME.0b013e318279bd4a.
   PubMed Web of Science ®Google Scholar
• Skiba MA, Bell RJ, Islam RM, et al. Androgens during the reproductive years, what’s normal for women? J Clin Endocrinol Metab. 2019;104(11):5382–5392. doi: 10.1210/jc.2019-01357.
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847–3853. doi: 10.1210/jc.2005-0212.
   PubMed Web of Science ®Google Scholar
• Davis SR, Bell RJ, Robinson PJ, et al. Testosterone and estrone increase from the age of 70 years: findings from the sex hormones in older women study. J Clin Endocrinol Metab. 2019;104(12):6291–6300. doi: 10.1210/jc.2019-00743.
   PubMed Web of Science ®Google Scholar
• Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab. 2010;95(10):4542–4548. doi: 10.1210/jc.2010-1314.
   PubMed Web of Science ®Google Scholar
• Robman LD, Guymer RH, Wolfe R, et al. Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly”(ASPREE)-AMD trial. Contemp Clin Trials Commun. 2020;20:100667. doi: 10.1016/j.conctc.2020.100667.
   PubMed Web of Science ®Google Scholar
• A.I. Group. Study design of ASPirin in reducing events in the elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555–564.
   PubMed Web of Science ®Google Scholar
• Teng E, Chui H. The modified mini-mental state examination (3MS). Can J Psychiatry. 1987;41(2):114–121.
   Google Scholar
• Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6(3):493–508. doi: 10.2190/UURL-2RYU-WRYD-EY3K.
   PubMed Web of Science ®Google Scholar
• Wolfe R, Murray AM, Woods RL, et al. The aspirin in reducing events in the elderly trial: statistical analysis plan. London (UK): SAGE Publications Sage UK; 2018.
   Google Scholar
• Harwood DT, Handelsman DJ. Development and validation of a sensitive liquid chromatography–tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta. 2009;409(1-2):78–84. doi: 10.1016/j.cca.2009.09.003.
   PubMed Web of Science ®Google Scholar
• Keski-Rahkonen P, Desai R, Jimenez M, et al. Measurement of estradiol in human serum by LC-MS/MS using a novel estrogen-specific derivatization reagent. Anal Chem. 2015;87(14):7180–7186. doi: 10.1021/acs.analchem.5b01042.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Hirani V, et al. Temporal trend in androgen status and androgen-sensitive outcomes in older men. J Clin Endocrinol Metab. 2016;101(4):1836–1846. doi: 10.1210/jc.2015-3810.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):573–577. doi: 10.7326/0003-4819-147-8-200710160-00010.
   PubMed Web of Science ®Google Scholar
• Spoletini I, Vitale C, Pelliccia F, et al. Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric. 2014;17(6):625–634. doi: 10.3109/13697137.2014.887669.
   PubMed Web of Science ®Google Scholar
• Rosano GM. Androgens and coronary artery disease. A sex-specific effect of sex hormones? Eur Heart J. 2000;21(11):868–871. doi: 10.1053/euhj.1999.2050.
   PubMed Web of Science ®Google Scholar
• Labrie F, Bélanger A, Pelletier G, et al. Science of intracrinology in postmenopausal women. Menopause. 2017;24(6):702–712. doi: 10.1097/GME.0000000000000808.
   PubMedGoogle Scholar
• Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78(3):C113–C118. doi: 10.1016/0303-7207(91)90116-a.
   PubMed Web of Science ®Google Scholar
• Davis SR, Martinez-Garcia A, Robinson PJ, et al. Estrone is a strong predictor of circulating estradiol in women age 70 years and older. J Clin Endocrinol Metab. 2020;105(9):e3348–e3354.
   PubMed Web of Science ®Google Scholar
• Azene Z, Davis SR, McNeil JJ, et al. Estrone, sex hormone binding globulin, and lipid profiles in older women: an observational study. Climacteric. 2023;26(2):114–120. doi: 10.1080/13697137.2023.2165908.
   PubMed Web of Science ®Google Scholar
• Simpson ER, Davis SR. Minireview: aromatase and the regulation of estrogen biosynthesis–some new perspectives. Endocrinology. 2001;142(11):4589–4594. doi: 10.1210/endo.142.11.8547.
   PubMed Web of Science ®Google Scholar
• Shufelt C, Bretsky P, Almeida CM, et al. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab. 2010;95(11):4985–4992. doi: 10.1210/jc.2010-0143.
   PubMed Web of Science ®Google Scholar
• Cappola AR, Xue Q-L, Walston JD, et al. DHEAS levels and mortality in disabled older women: the Women’s Health and Aging Study I. J Gerontol A Biol Sci Med Sci. 2006;61(9):957–962. doi: 10.1093/gerona/61.9.957.
   PubMed Web of Science ®Google Scholar
• Jiménez MC, Sun Q, Schürks M, et al. Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke. 2013;44(7):1784–1789. doi: 10.1161/STROKEAHA.111.000485.
   PubMed Web of Science ®Google Scholar
• Hemachandra C, Bell RJ, Islam MR, et al. The association between testosterone and depression in postmenopausal women: a systematic review of observational studies. Maturitas. 2022;68:62–70.
   Google Scholar
• Siddiqi HK, Kiss D, Rader D. HDL-cholesterol and cardiovascular disease: rethinking our approach. Curr Opin Cardiol. 2015;30(5):536–542. doi: 10.1097/HCO.0000000000000211.
   PubMed Web of Science ®Google Scholar
• Bittner V, Johnson BD, Zineh I, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J. 2009;157(3):548–555. doi: 10.1016/j.ahj.2008.11.014.
   PubMed Web of Science ®Google Scholar
• Wan K, Zhao J, Huang H, et al. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization. PLoS One. 2015;10(4):e0123521. doi: 10.1371/journal.pone.0123521.
   PubMed Web of Science ®Google Scholar
• Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97(7):1007–1009. doi: 10.1016/j.amjcard.2005.10.036.
   PubMed Web of Science ®Google Scholar
• Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/hdl-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb. 2003;10(3):186–191. doi: 10.5551/jat.10.18614564088
   PubMedGoogle Scholar
• Hanak V, Munoz J, Teague J, et al. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol. 2004;94(2):219–222. doi: 10.1016/j.amjcard.2004.03.069.
   PubMed Web of Science ®Google Scholar